Breakdown | ||||
Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
37.11B | 35.40B | 33.21B | 25.94B | 18.34B | Gross Profit |
9.60B | 9.68B | 9.38B | 6.17B | 2.08B | EBIT |
6.95B | 7.19B | 6.84B | 4.16B | 429.02M | EBITDA |
21.53B | 21.18B | 19.61B | 14.59B | 9.76B | Net Income Common Stockholders |
3.51B | 4.09B | 6.02B | 3.28B | 597.75M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
11.69B | 11.80B | 15.69B | 11.22B | 11.11B | Total Assets |
75.36B | 69.44B | 72.26B | 62.96B | 54.74B | Total Debt |
13.77B | 14.13B | 20.99B | 19.49B | 19.36B | Net Debt |
2.08B | 5.03B | 5.30B | 8.26B | 8.25B | Total Liabilities |
21.43B | 20.43B | 30.06B | 26.40B | 23.70B | Stockholders Equity |
37.40B | 34.12B | 29.58B | 26.19B | 23.25B |
Cash Flow | Free Cash Flow | |||
2.71B | 4.26B | 3.93B | 1.56B | 2.28B | Operating Cash Flow |
17.47B | 18.33B | 17.03B | 11.42B | 9.70B | Investing Cash Flow |
-14.61B | -14.66B | -12.19B | -9.65B | -5.36B | Financing Cash Flow |
-3.56B | -9.62B | -382.90M | -2.01B | -2.98B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
81 Outperform | ¥40.50B | 9.08 | 3.74% | 7.88% | 39.72% | ||
80 Outperform | ¥27.12B | 7.94 | 3.69% | 3.61% | -14.91% | ||
74 Outperform | ¥26.89B | 7.53 | 1.88% | 36.47% | 454.91% | ||
62 Neutral | $11.97B | 10.08 | -7.46% | 2.96% | 7.37% | -8.22% | |
57 Neutral | ¥34.40B | 498.77 | 5.88% | -46.16% | -98.31% |